Global Intracranial Stents Market 2018-2022
About Intracranial Stents
Intracranial stents are used for the treatment of atherosclerosis in the carotid or intracranial arteries. Stents are permanent implants that open the blocked arteries, allowing increased blood flow to the brain.
Technavio’s analysts forecast the global intracranial stents market to grow at a CAGR of 14.85% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global intracranial stents market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Intracranial Stents Market 2018-2022
Technavio recognizes the following companies as the key players in the global intracranial stents market: Acandis, Phenox, Medtronic, MicroPort Scientific, and DePuy Synthes.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is growing emergence of dual characteristics intracranial stents. The global intracranial stents market is concentrated with a few prominent vendors that hold the majority market share. To remain competitive in the global market, key vendors are focusing on the introduction of innovative technology for better clinical outcomes.”
According to the report, one driver in the market is growing prevalence of aneurysms and related disorders. The high prevalence of brain aneurysms and cerebral disorders is the major contributor to the growth of the global intracranial stents market. Brain aneurysms and other common neurological disorders are encountered by 2%-6% people globally, which has a positive impact on the growth of this market.
Further, the report states that one challenge in the market is high cost associated with stenting procedures. Intracranial stent placement has been successfully evaluated as a new method of treatment for symptomatic intracranial stenosis in selected patients. The FDA has also approved intracranial stent treatment for symptomatic atherosclerotic intracranial lesions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook